Top

Published in:

Open Access 01-01-2015 | Short Commentary

Oculoleptomeningeal Amyloidosis associated with transthyretin Leu12Pro in an African patient

Authors: P. McColgan, S. Viegas, S. Gandhi, K. Bull, R. Tudor, F. Sheikh, J. Pinney, M. Fontana, D. Rowczenio, J. D. Gillmore, J. A. Gilbertson, C. J. Whelan, S. Shah, Z. Jaunmuktane, J. L. Holton, J. M. Schott, D. J. Werring, P. N. Hawkins, M. M. Reilly

Published in: Journal of Neurology | Issue 1/2015

Abstract

Oculoleptomeningeal amyloidosis is a rare manifestation of hereditary transthyretin (TTR) amyloidosis. Here, we present the first case of leptomeningeal amyloidosis associated with the TTR variant Leu12Pro mutation in an African patient. A 43-year-old right-handed Nigerian man was referred to our centre with rapidly progressive neurological decline. He presented initially with weight loss, confusion, fatigue, and urinary and erectile dysfunction. He then suffered recurrent episodes of slurred speech with right-sided weakness. He went on to develop hearing difficulties and painless paraesthesia. Neurological examination revealed horizontal gaze-evoked nystagmus, brisk jaw jerk, increased tone, brisk reflexes throughout and bilateral heel-shin ataxia. Magnetic resonance imaging showed extensive leptomeningeal enhancement. Cerebrospinal fluid analysis showed a raised protein of 6.4 g/dl. Nerve conduction studies showed an axonal neuropathy. Echocardiography was characteristic of cardiac amyloid. TTR gene sequencing showed that he was heterozygous for the leucine 12 proline mutation. Meningeal and brain biopsy confirmed widespread amyloid angiopathy. TTR amyloidosis is a rare cause of leptomeningeal enhancement, but should be considered if there is evidence of peripheral or autonomic neuropathy with cardiac or ocular involvement. The relationship between different TTR mutations and clinical phenotype, disease course, and response to treatment remains unclear.

Costa PP, Figueira AS, Bravo FR (1978) Amyloid fibril protein related to prealbumin in familial amyloidotic polyneuropathy. Proc Natl Acad Sci USA 75(9):4499–4503PubMedCentralCrossRefPubMed

Soprano DR, Herbert J, Soprano KJ, Schon EA, Goodman DS (1985) Demonstration of transthyretin mRNA in the brain and other extrahepatic tissues in the rat. J Biol Chem 260(21):11793–11798PubMed

Plante-Bordeneuve V, Said G (2011) Familial amyloid polyneuropathy. Lancet Neurol 10(12):1086–1097CrossRefPubMed

Suhr OB, Andersen O, Aronsson T, Jonasson J, Kalimo H, Lundahl C et al (2009) Report of five rare or previously unknown amyloidogenic transthyretin mutations disclosed in Sweden. Amyloid Int J Exp Clin Invest Off J Int Soc Amyloid 16(4):208–214CrossRef

Jin K, Sato S, Takahashi T, Nakazaki H, Date Y, Nakazato M et al (2004) Familial leptomeningeal amyloidosis with a transthyretin variant Asp18Gly representing repeated subarachnoid haemorrhages with superficial siderosis. J Neurol Neurosurg Psychiatry 75(10):1463–1466PubMedCentralCrossRefPubMed

Garzuly F, Vidal R, Wisniewski T, Brittig F, Budka H (1996) Familial meningocerebrovascular amyloidosis, Hungarian type, with mutant transthyretin (TTR Asp18Gly). Neurology 47(6):1562–1567CrossRefPubMed

Douglass C, Suvarna K, Reilly MM, Hawkins PN, Hadjivassiliou M (2007) A novel amyloidogenic transthyretin variant, Gly53Ala, associated with intermittent headaches and ataxia. J Neurol Neurosurg Psychiatry 78(2):193–195PubMedCentralCrossRefPubMed

Brett M, Persey MR, Reilly MM, Revesz T, Booth DR, Booth SE et al (1999) Transthyretin Leu12Pro is associated with systemic, neuropathic and leptomeningeal amyloidosis. Brain J Neurol 122(Pt 2):183–190CrossRef

Nakamura M, Yamashita T, Ueda M, Obayashi K, Sato T, Ikeda T et al (2005) Neuroradiologic and clinicopathologic features of oculoleptomeningeal type amyloidosis. Neurology 65(7):1051–1056CrossRefPubMed

10.

Herrick MK, DeBruyne K, Horoupian DS, Skare J, Vanefsky MA, Ong T (1996) Massive leptomeningeal amyloidosis associated with a Val30Met transthyretin gene. Neurology 47(4):988–992CrossRefPubMed

11.

Goren H, Steinberg MC, Farboody GH (1980) Familial oculoleptomeningeal amyloidosis. Brain J Neurol 103(3):473–495CrossRef

12.

Salvi F, Pastorelli F, Plasmati R, Bartolomei I, Dall’Osso D, Rapezzi C (2012) Genotypic and phenotypic correlation in an Italian population of hereditary amyloidosis TTR-related (HA-TTR): clinical and neurophysiological aids to diagnosis and some reflections on misdiagnosis. Amyloid Int J Exp Clin Invest Off J Int Soc Amyloid 19(Suppl 1):58–60CrossRef

13.

Shimizu Y, Takeuchi M, Matsumura M, Tokuda T, Iwata M (2006) A case of biopsy-proven leptomeningeal amyloidosis and intravenous Ig-responsive polyneuropathy associated with the Ala25Thr transthyretin gene mutation. Amyloid Int J Exp Clin Invest Off J Int Soc Amyloid 13(1):37–41CrossRef

14.

Hagiwara K, Ochi H, Suzuki S, Shimizu Y, Tokuda T, Murai H et al (2009) Highly selective leptomeningeal amyloidosis with transthyretin variant Ala25Thr. Neurology 72(15):1358–1360CrossRefPubMed

15.

Liepnieks JJ, Dickson DW, Benson MD (2011) A new transthyretin mutation associated with leptomeningeal amyloidosis. Amyloid Int J Exp Clin Invest Off J Int Soc Amyloid 18(Suppl 1):155–157

16.

Ellie E, Camou F, Vital A, Rummens C, Grateau G, Delpech M et al (2001) Recurrent subarachnoid hemorrhage associated with a new transthyretin variant (Gly53Glu). Neurology 57(1):135–137CrossRefPubMed

17.

Barreiros AP, Post F, Hoppe-Lotichius M, Linke RP, Vahl CF, Schafers HJ et al (2010) Liver transplantation and combined liver-heart transplantation in patients with familial amyloid polyneuropathy: a single-center experience. Liver Trans Off Publ Am Assoc Study Liver Dis Int Liver Trans Soc 16(3):314–323

18.

Urban PP, Hertkorn C, Schattenberg JM, Gawehn J, Hagele S, Wunsch M et al (2006) Leptomeningeal familial amyloidosis: a rare differential diagnosis of leptomeningeal enhancement in MRI. J Neurol 253(9):1238–1240CrossRefPubMed

19.

Uemichi T, Uitti RJ, Koeppen AH, Donat JR, Benson MD (1999) Oculoleptomeningeal amyloidosis associated with a new transthyretin variant Ser64. Arch Neurol 56(9):1152–1155CrossRefPubMed

20.

Klein CJ, Nakumura M, Jacobson DR, Lacy MQ, Benson MD, Petersen RC (1998) Transthyretin amyloidosis (serine 44) with headache, hearing loss, and peripheral neuropathy. Neurology 51(5):1462–1464CrossRefPubMed

21.

Hirai T, Ando Y, Yamura M, Kitajima M, Hayashida Y, Korogi Y et al (2005) Transthyretin-related familial amyloid polyneuropathy: evaluation of CSF enhancement on serial T1-weighted and fluid-attenuated inversion recovery images following intravenous contrast administration. AJNR Am J Neuroradiol 26(8):2043–2048PubMed

22.

Nakagawa K, Sheikh SI, Snuderl M, Frosch MP, Greenberg SM (2008) A new Thr49Pro transthyretin gene mutation associated with leptomeningeal amyloidosis. J Neurol Sci 272(1–2):186–190CrossRefPubMed

23.

Schweitzer K, Ehmann D, Garcia R, Alport E (2009) Oculoleptomeningeal amyloidosis in 3 individuals with the transthyretin variant Tyr69His. Can J Ophthalmol J Can D’ophtalmol 44(3):317–319CrossRef

24.

Blevins G, Macaulay R, Harder S, Fladeland D, Yamashita T, Yazaki M et al (2003) Oculoleptomeningeal amyloidosis in a large kindred with a new transthyretin variant Tyr69His. Neurology 60(10):1625–1630CrossRefPubMed

25.

Roe RH, Fisher Y, Eagle RC Jr, Fine HF, Cunningham ET Jr (2007) Oculoleptomeningeal amyloidosis in a patient with a TTR Val30Gly mutation in the transthyretin gene. Ophthalmology 114(11):e33–e37CrossRefPubMed

26.

Dowell JD, Fleck JD, Vakili ST, Benson MD (2007) Familial oculoleptomeningeal amyloidosis associated with primary angiitis of the CNS. Neurology 68(1):77–78CrossRefPubMed

27.

Petersen RB, Goren H, Cohen M, Richardson SL, Tresser N, Lynn A et al (1997) Transthyretin amyloidosis: a new mutation associated with dementia. Ann Neurol 41(3):307–313CrossRefPubMed

28.

Furuya H, Yoshioka K, Sasaki H, Sakaki Y, Nakazato M, Matsuo H et al (1987) Molecular analysis of a variant type of familial amyloidotic polyneuropathy showing cerebellar ataxia and pyramidal tract signs. J Clin Investig 80(6):1706–1711PubMedCentralCrossRefPubMed

29.

Horowitz S, Thomas C, Gruener G, Nand S, Shea JF (1998) MR of leptomeningeal spinal and posterior fossa amyloid. AJNR Am J Neuroradiol 19(5):900–902PubMed

30.

Taratuto AL (2010) BH, Salvatico R., Dogan A., Klein C., Dyck P.J. Leptomeningeal amyloidosis in an Argentinian patient of basque descent [Abstract]. J Neuropathol Exp Neurol 5:555

31.

Charidimou A, Peeters A, Fox Z, Gregoire SM, Vandermeeren Y, Laloux P et al (2012) Spectrum of transient focal neurological episodes in cerebral amyloid angiopathy: multicentre magnetic resonance imaging cohort study and meta-analysis. Stroke J Cereb Cir 43(9):2324–2330CrossRef

32.

Ando Y, Terazaki H, Nakamura M, Ando E, Haraoka K, Yamashita T et al (2004) A different amyloid formation mechanism: de novo oculoleptomeningeal amyloid deposits after liver transplantation. Transplantation 77(3):345–349CrossRefPubMed

33.

Terazaki H, Ando Y, Nakamura M, Obayashi K, Misumi S, Shoji S et al (2001) Variant transthyretin in blood circulation can transverse the blood-cerebrospinal barrier: qualitative analyses of transthyretin metabolism in sequential liver transplantation. Transplantation 72(2):296–299CrossRefPubMed

34.

Yamashita T, Ando Y, Ueda M, Nakamura M, Okamoto S, Zeledon ME et al (2008) Effect of liver transplantation on transthyretin Tyr114Cys-related cerebral amyloid angiopathy. Neurology 70(2):123–128CrossRefPubMed

35.

Sekijima Y, Wiseman RL, Matteson J, Hammarstrom P, Miller SR, Sawkar AR et al (2005) The biological and chemical basis for tissue-selective amyloid disease. Cell 121(1):73–85CrossRefPubMed

Title: Oculoleptomeningeal Amyloidosis associated with transthyretin Leu12Pro in an African patient
Authors: P. McColgan
S. Viegas
S. Gandhi
K. Bull
R. Tudor
F. Sheikh
J. Pinney
M. Fontana
D. Rowczenio
J. D. Gillmore
J. A. Gilbertson
C. J. Whelan
S. Shah
Z. Jaunmuktane
J. L. Holton
J. M. Schott
D. J. Werring
P. N. Hawkins
M. M. Reilly
Publication date: 01-01-2015
Publisher: Springer Berlin Heidelberg
Published in: Journal of Neurology / Issue 1/2015
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-014-7594-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Oculoleptomeningeal Amyloidosis associated with transthyretin Leu12Pro in an African patient

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2015

What’s new in the surgical management of traumatic brain injury?

Pathogenesis of mild parkinsonian signs in aging

Erratum to: Long-term outcome of epilepsy in patients with Prader–Willi syndrome

Wilhelm Uhthoff (1853–1927)

Long-term outcome of epilepsy in patients with Prader–Willi syndrome

Genome sequencing identifies a novel mutation in ATP1A3 in a family with dystonia in females only